- Home
- MTDR vs AXSM Comparison
MTDR vs AXSM Comparison
Compare MTDR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTDR
- AXSM
- Stock Information
- Founded
- MTDR 2003
- AXSM 2012
- Country
- MTDR United States
- AXSM United States
- Employees
- MTDR N/A
- AXSM N/A
- Industry
- MTDR Oil & Gas Production
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- MTDR Energy
- AXSM Health Care
- Exchange
- MTDR Nasdaq
- AXSM Nasdaq
- Market Cap
- MTDR 5.4B
- AXSM 5.9B
- IPO Year
- MTDR 2012
- AXSM 2015
- Fundamental
- Price
- MTDR $42.56
- AXSM $151.76
- Analyst Decision
- MTDR Buy
- AXSM Strong Buy
- Analyst Count
- MTDR 15
- AXSM 20
- Target Price
- MTDR $62.79
- AXSM $176.00
- AVG Volume (30 Days)
- MTDR 1.7M
- AXSM 595.0K
- Earning Date
- MTDR 10-21-2025
- AXSM 11-03-2025
- Dividend Yield
- MTDR 3.60%
- AXSM N/A
- EPS Growth
- MTDR N/A
- AXSM N/A
- EPS
- MTDR 6.24
- AXSM N/A
- Revenue
- MTDR $3,556,751,000.00
- AXSM $561,263,000.00
- Revenue This Year
- MTDR $14.61
- AXSM $63.66
- Revenue Next Year
- MTDR $1.29
- AXSM $54.46
- P/E Ratio
- MTDR $6.67
- AXSM N/A
- Revenue Growth
- MTDR 14.75
- AXSM 65.83
- 52 Week Low
- MTDR $35.19
- AXSM $75.56
- 52 Week High
- MTDR $64.05
- AXSM $152.94
- Technical
- Relative Strength Index (RSI)
- MTDR 57.74
- AXSM 71.28
- Support Level
- MTDR $39.93
- AXSM $147.97
- Resistance Level
- MTDR $42.31
- AXSM $152.94
- Average True Range (ATR)
- MTDR 1.37
- AXSM 4.91
- MACD
- MTDR 0.42
- AXSM 0.48
- Stochastic Oscillator
- MTDR 96.64
- AXSM 93.17
About MTDR Matador Resources Company
Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.